2024

2024

• Antibiotice Iași continued to invest in the consolidation and development of the company, pursuing strategic directions essential for increasing operational efficiency and developing a sustainable business. One of the most important projects implemented was the 2.5 MW photovoltaic park that provides over 25% of the company’s energy needs from renewable sources. This initiative is part of Antibiotice Iași’s commitment to green energy and reducing its carbon footprint. In parallel, the company began implementing a 1.2 MW photovoltaic park on buildings. Together, the two photovoltaic parks will provide approximately 35% of the energy consumption of the industrial platform, thus supporting the company’s long-term sustainability.
• Modernizing the production infrastructure was another priority, with significant investments aimed at expanding and improving production facilities. This year, the design of a site for the production of sterile injectable solutions was started, which will allow the portfolio to be completed with new molecules that will increase the company’s competitiveness on the international market. At the same time, Antibiotice Iași continued to invest in the digitalization of internal processes, implementing advanced technological solutions.
• Antibiotice Iași organized the “Investor Day” event, providing an opportunity for investors to discuss the company’s financial performance and medium- and long-term development plans. This event highlighted the company’s commitment to transparency and financial stability, and also provided the company with future strategies to strengthen its market position.
• One of the most remarkable moments of 2024 was the company’s stock market performance. Antibiotice Iași shares (symbol ATB) recorded a spectacular increase, which led to the company’s inclusion in the BET index of the Bucharest Stock Exchange, the benchmark index of the 20 most traded listed companies. This achievement confirms the company’s financial success and stability on the capital market.
• Also in 2024, Antibiotice Iași launched the VetAria+ range of veterinary nutritional supplements, designed to support the health of pets. The range includes products for various conditions, such as those of the joints, the liver system, the urinary tract and for strengthening immunity. This initiative is part of the portfolio diversification strategy and was officially presented at the “An Extra Good” symposium in July 2024, which was attended by over 120 veterinarians.